Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dementia, Senile”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT01867775
What this trial is testing

Mirtazapine for Sleep Disorders in Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseSleep Disorders
Brasilia University Hospital 30
Testing effectiveness (Phase 2)Study completedNCT05323812
What this trial is testing

ASURE: Alzheimer Study Using oRal Edaravone

Who this might be right for
Alzheimer Disease
Treeway B.V. 61
Early research (Phase 1)Study completedNCT03277573
What this trial is testing

Salsalate in Patients Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Adam Boxer 40
Not applicableNot Yet RecruitingNCT07631247
What this trial is testing

IPath for CP Pilot

Who this might be right for
Depression - Major Depressive Disorder
Dartmouth-Hitchcock Medical Center 15
Not applicableUnknownNCT01128725
What this trial is testing

Truncated and Extended Forms of Amyloid Beta Peptides in Alzheimer's Disease: Genesis, Toxicity and Identification as Biological Markers

Who this might be right for
Alzheimer Disease
Centre Hospitalier Universitaire de Nice 100
Very early researchStudy completedNCT03587376
What this trial is testing

Characterization of T-Cell Response in Participants Previously Treated With JNJ-54861911 (Atabecestat)

Who this might be right for
Alzheimer Disease
Janssen Research & Development, LLC 9
Large-scale testing (Phase 3)Ended earlyNCT02484547
What this trial is testing

221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Biogen 1,643
Not applicableLooking for participantsNCT07006155
What this trial is testing

Biograph Vision 600 Versus Biograph Vision.X PET/CT

Who this might be right for
CancerAlzheimer Disease
Valentina Garibotto 40
Testing effectiveness (Phase 2)UnknownNCT04169126
What this trial is testing

Topography Staging and Dual Phase Image Quantification of Tau PET in Cognitive Impairment Subjects

Who this might be right for
Alzheimer's Disease
Chang Gung Memorial Hospital 300
Testing effectiveness (Phase 2)Study completedNCT02707458
What this trial is testing

Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

Who this might be right for
Dementia of the Alzheimer TypeAge-related Cognitive DeclineMild Cognitive Impairment Due to Alzheimer Disease
Douglas Mental Health University Institute 23
Not applicableStudy completedNCT07054385
What this trial is testing

I-CARE Rural Pilot: Intervention for Rural-Dwelling Dementia Caregivers

Who this might be right for
Caregiver BurdenAlzheimer Disease
Richard Holden 41
Not applicableStudy completedNCT02963415
What this trial is testing

Concurrent Aerobic Exercise and Virtual Reality Cognitive Training

Who this might be right for
Preclinical Alzheimer's Disease
University of Minnesota 39
Testing effectiveness (Phase 2)Study completedNCT00884507
What this trial is testing

RO5313534 as Add-on to Donepezil Treatment in Patients With Mild to Moderate Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
Hoffmann-La Roche 389
Early research (Phase 1)Study completedNCT03943264
What this trial is testing

A Biomarker-directed Study of XPro1595 in Patients With Alzheimer's

Who this might be right for
Alzheimer Disease
Inmune Bio, Inc. 20
Testing effectiveness (Phase 2)Ended earlyNCT02033941
What this trial is testing

Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD)

Who this might be right for
Alzheimer's Disease
Hillel Grossman 10
Large-scale testing (Phase 3)Looking for participantsNCT07284472
What this trial is testing

Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia

Who this might be right for
Agitation Associated With Alzheimer's Disease Dementia
Exciva GmbH 300
Not applicableUnknownNCT03378037
What this trial is testing

The Effects of Acupuncture on the Risk of AD After TBI

Who this might be right for
Brain Injuries, Traumatic
China Medical University Hospital 76
Not applicableUnknownNCT04368572
What this trial is testing

Efficacy of Hypnosis on Pain and Anxiety During Lumbar Puncture for Etiological Diagnosis of Cognitive Impairment

Who this might be right for
Cognitive ImpairmentAlzheimer's Disease
Gérond'if 60
Not applicableWithdrawnNCT07361601
What this trial is testing

Implementation of AIP Services for Older Adults With AD

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
Northwestern University
Early research (Phase 1)Study completedNCT01348737
What this trial is testing

Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers

Who this might be right for
Alzheimer's DiseaseSafetyTolerability+2 more
AstraZeneca 72
Next Page